iRadimed (NASDAQ:IRMD) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $0.54,…
iRadimed (NASDAQ:IRMD) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.54, beating the consensus estimate of $0.46 by $0.08 per share. Revenue came in at $22.7M, beating the estimate of $21.7M.
iRadimed's stock moved following the earnings release. The stock currently trades at $104.95 with a market capitalization of $1.2B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · IRMD
$86.46
Down: -$0.20 · -0.23%
Live quote updated
Keep reading
